Market Overview:
The global mRNA sequencing market is expected to grow at a CAGR of 16.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for mRNA sequencing services from pharmaceutical and biotechnology companies, academic research and government institutes, hospitals and diagnostic centers, and other end users. The PCR segment is expected to account for the largest share of the global mRNA sequencing market in 2018. However, the microarray segment is projected to grow at a higher CAGR during the forecast period. North America accounted for the largest share of the global mRNA sequencing market in 2017, followed by Europe and Asia Pacific.
Product Definition:
M RNA sequencing is a molecular biology technique that allows researchers to determine the sequence of nucleotides in an mRNA molecule. This information can be used to identify the genes that are expressed by a particular cell or tissue, and can also help researchers understand how genes are regulated. M RNA sequencing is important because it provides scientists with valuable information about gene expression patterns, which can be used to identify and study disease-causing genes.
PCR:
Polymerase Chain Reaction (PCR) is a technique used for repeated amplification of DNA. It is also used in the diagnosis of genetic disorders and infections. The technology has advanced over the years, and researchers have found new ways to use it such as detecting recent mutations, tracking down drug resistivity genes or even measuring viral load in patients infected with HIV-1.
Microarray:
Microarray is a technique that involves the hybridization of an oligonucleotide probe to a large number of genes simultaneously. The array allows for the rapid scanning of nucleic acids, which in turn helps in identifying and quantifying gene expression with high sensitivity and accuracy. It also facilitates the detection of novel targets for research as well as diagnostic purposes.
Application Insights:
The academic research segment dominated the market in 2017 and is expected to witness a CAGR of XX% during the forecast period. The growth can be attributed to an increase in government funding for research studies at institutions, such as National Cancer Center, Japan; Memorial Hermann Health System-Houston; University of Texas MD Anderson Cancer Center-Houston; and others.
The pharmaceutical industry accounted for more than 25% share in 2017 owing to high demand from companies, such as Merck KGaA., Sepracor Inc., Pfizer Inc., Amgen Inc., Eli Lilly & Co.; Astrazeneca L.P.; Bayer HealthCare LLC.; Bristol-Myers Squibb Company; sanofi Aventis ULC.; and others. mRNA sequencing has proven beneficial in identifying new drug targets by analyzing gene expression patterns characteristic of healthy human body tissues or diseased tissues/organs (in vitro).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a well-established research framework, which is supportive of advanced technologies. Moreover, increasing investments by pharmaceutical and biotechnology companies for drug discovery activities are expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising healthcare expenditure and initiatives undertaken by governments in developing economies such as China and India for establishing genomic centers that can accelerate drug discovery processes. ‘’ 12th Genomics Conference Americas ‘19’; Latin American genomics conference 2019 will be held in Brazil The sequencing revolution has led researchers from around the world towards deep dives into genetic material with applications across various fields including medicine, forensics, agriculture & food science among others.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of cancer and other diseases
- Growing number of research institutes and universities
- Technological advancements in sequencing platforms
- Increasing public-private investments in life sciences
Scope Of The Report
Report Attributes
Report Details
Report Title
mRNA Sequencing Market Research Report
By Type
PCR, Microarray, Sequencing
By Application
Pharmaceutical and Biotechnology, Academic Research and Government Institutes, Hospitals and Diagnostic Centers
By Companies
Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global mRNA Sequencing Market Report Segments:
The global mRNA Sequencing market is segmented on the basis of:
Types
PCR, Microarray, Sequencing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and Biotechnology, Academic Research and Government Institutes, Hospitals and Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Illumina
- QIAGEN (Exiqon)
- Agilent Technologies
- Roche
- GE Healthcare
- Bio-Rad Laboratories
- Fluidigm
Highlights of The mRNA Sequencing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PCR
- Microarray
- Sequencing
- By Application:
- Pharmaceutical and Biotechnology
- Academic Research and Government Institutes
- Hospitals and Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the mRNA Sequencing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
MRNA sequencing is a technique used to identify the sequence of messenger RNA (mRNA) in a sample. mRNA sequences can be used to identify the genes and proteins that are expressed in a cell or tissue.
Some of the major companies in the mrna sequencing market are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm.
The mrna sequencing market is expected to register a CAGR of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 mRNA Sequencing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 mRNA Sequencing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 mRNA Sequencing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the mRNA Sequencing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global mRNA Sequencing Market Size & Forecast, 2018-2028
4.5.1 mRNA Sequencing Market Size and Y-o-Y Growth
4.5.2 mRNA Sequencing Market Absolute $ Opportunity
Chapter 5 Global mRNA Sequencing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 mRNA Sequencing Market Size Forecast by Type
5.2.1 PCR
5.2.2 Microarray
5.2.3 Sequencing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global mRNA Sequencing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 mRNA Sequencing Market Size Forecast by Applications
6.2.1 Pharmaceutical and Biotechnology
6.2.2 Academic Research and Government Institutes
6.2.3 Hospitals and Diagnostic Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global mRNA Sequencing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 mRNA Sequencing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America mRNA Sequencing Analysis and Forecast
9.1 Introduction
9.2 North America mRNA Sequencing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America mRNA Sequencing Market Size Forecast by Type
9.6.1 PCR
9.6.2 Microarray
9.6.3 Sequencing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America mRNA Sequencing Market Size Forecast by Applications
9.10.1 Pharmaceutical and Biotechnology
9.10.2 Academic Research and Government Institutes
9.10.3 Hospitals and Diagnostic Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe mRNA Sequencing Analysis and Forecast
10.1 Introduction
10.2 Europe mRNA Sequencing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe mRNA Sequencing Market Size Forecast by Type
10.6.1 PCR
10.6.2 Microarray
10.6.3 Sequencing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe mRNA Sequencing Market Size Forecast by Applications
10.10.1 Pharmaceutical and Biotechnology
10.10.2 Academic Research and Government Institutes
10.10.3 Hospitals and Diagnostic Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific mRNA Sequencing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific mRNA Sequencing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific mRNA Sequencing Market Size Forecast by Type
11.6.1 PCR
11.6.2 Microarray
11.6.3 Sequencing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific mRNA Sequencing Market Size Forecast by Applications
11.10.1 Pharmaceutical and Biotechnology
11.10.2 Academic Research and Government Institutes
11.10.3 Hospitals and Diagnostic Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America mRNA Sequencing Analysis and Forecast
12.1 Introduction
12.2 Latin America mRNA Sequencing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America mRNA Sequencing Market Size Forecast by Type
12.6.1 PCR
12.6.2 Microarray
12.6.3 Sequencing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America mRNA Sequencing Market Size Forecast by Applications
12.10.1 Pharmaceutical and Biotechnology
12.10.2 Academic Research and Government Institutes
12.10.3 Hospitals and Diagnostic Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) mRNA Sequencing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) mRNA Sequencing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) mRNA Sequencing Market Size Forecast by Type
13.6.1 PCR
13.6.2 Microarray
13.6.3 Sequencing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) mRNA Sequencing Market Size Forecast by Applications
13.10.1 Pharmaceutical and Biotechnology
13.10.2 Academic Research and Government Institutes
13.10.3 Hospitals and Diagnostic Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 mRNA Sequencing Market: Competitive Dashboard
14.2 Global mRNA Sequencing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Illumina
14.3.3 QIAGEN (Exiqon)
14.3.4 Agilent Technologies
14.3.5 Roche
14.3.6 GE Healthcare
14.3.7 Bio-Rad Laboratories
14.3.8 Fluidigm
